Form 4: AdaptHealth CCO Granted 48,807 Restricted Stock Units

AdaptHealth's Chief Commercial Officer, Russell E. Schuster III, received a grant of 48,807 restricted stock units, aligning executive incentives with shareholder interests.

Summary

• Russell E. Schuster III, the Chief Commercial Officer of AdaptHealth Corp. (AHCO), acquired 48,807 shares of common stock.
• The transaction occurred on January 30, 2026, and was reported on February 3, 2026.
• These shares represent restricted stock units (RSUs) granted at a price of $0, which will be settled in common stock upon vesting.
• Following this transaction, Mr. Schuster beneficially owns 147,813 shares directly.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a standard executive compensation practice that aligns management's interests with long-term shareholder value, without indicating any significant operational or financial changes.

Positives

• The grant of restricted stock units aligns the Chief Commercial Officer's long-term incentives with the company's performance and shareholder value.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and transparent approach to executive compensation.

Future Outlook

The filing indicates that the acquired restricted stock units will be settled in common stock upon vesting, implying future share issuance contingent on vesting conditions.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units to a Chief Commercial Officer is a standard practice in publicly traded companies within the healthcare services and medical equipment industry. This form of equity compensation is widely used to attract, retain, and incentivize key executives by linking their compensation directly to the company's long-term performance and stock price appreciation.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a common practice across the healthcare industry, comparable to compensation structures at companies like ResMed Inc. (RMD) or Invacare Corporation (IVC), which frequently utilize equity grants to align executive interests with shareholder returns.
• The grant size of 48,807 shares for a Chief Commercial Officer is within the typical range for a company of AdaptHealth's market capitalization, reflecting a competitive compensation package designed to retain top talent.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Chief Commercial Officer's incentives with shareholder interests, potentially fostering long-term value creation.
• Employees: This transaction is part of the company's executive compensation strategy, which can influence overall employee morale and retention strategies.

Next Steps

• The restricted stock units will vest according to their predetermined schedule, at which point they will be settled in common stock.

Key Dates

Keywords

AdaptHealth, AHCO, Restricted Stock Units, RSU Grant, Insider Transaction, Executive Compensation, Russell Schuster, Chief Commercial Officer, Form 4, Equity Compensation